PRAXPRAX

Buy more

Buy more at today's $329, already under our buy price.

6 good· Earnings beat

$328.64−17.57 (−5.07%)

Price at 3:03 PM ET

After hours · opens in 17h 23m

Healthcare · Mid-size company

Tell me when PRAX moves 5% in a day

The price we'd buy PRAX at comes with a free account

It also has the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.

What would change it

Sources

Yahoo Finance daily closes to Nov 9

Any one could move it to Keep

Compared with the S&P 500

15 points
worse in one day
34 points
worse in five trading days

+95.7% in a yearsince Nov 10, 2025

Earnings report

Latest results

Reported Monday before the open

EPS: −$3.23; vs −$3.63 expected, beat by 11%
The stock: +20%; On Monday, usually 5.6%

Our call is still Buy more after the results.

The news behind our call

written Monday, 5:29 PM ETMonday, 5:29 PM ET · 8 articles · 8 sources

PRAX holds approximately $1.3 billion in cash and investments.
PRAX reported a third-quarter loss smaller than analysts expected.

What changed

From Yahoo Finance, Benzinga, ChartMill and 4 more

PRAX rose 20.12% after an EPS beat, but operating and guidance confirmation remained limited.

Praxis Precision Medicines (PRAX) stock looks Rich against its Book Value
Monday
PRAX rose 20.12% after an EPS beat, but operating and guidance confirmation remained limited
Reported EPS was -$3.23 versus -$3.63 estimated, a $0.40 positive surprise and 11.13% beat for the fiscal period ended September 30, 2026. No explicit company guidance or guidance update was provided in the payload; next-year EPS growth was forecast at 26.84%.
Earnings · Monday
Praxis Precision Medicines, Inc. Reports Third quarter 2026 Financial results and provides Regulatory updates
Monday
Praxis Precision Medicines (NASDAQ:PRAX) Narrows Q3 loss ahead of two FDA decisions
Monday
Praxis Precision Medicines, Inc. (PRAX) stock price, news, quote and history
Monday
Praxis Precision Medicines Non-GAAP EPS of -$3.23 beats by $0.40
Monday
Praxis Precision Medicines provides Corporate update and reports Third quarter 2026 Financial results
Monday
Praxis Precision Medicines Inc (PRAX) stock price, Quote, news & History
Friday

Financials

Revenue grew 249% between FY 2023 and FY 2024, to $8.6M. It burned $323.6M of free cash in the last twelve months.

Revenue

$ · latest 8.6M

Net income

Still a lossFY25 vs FY24$ · latest −359M

EPS (diluted)

Still a lossFY25 vs FY24$ per share · latest -12.76

Free cash flow

$ · latest −324M

Margins

% of revenue

Operating-2340%Net-2137%

Cash and debt

latest balance sheet

Cash and investments$1.3B
Total debt$730K

It holds $1.3B in cash and investments against $730,000 of debt, which leaves $1.3B of net cash.

Key facts

Company value: $9.4B
Today's range: 319.34343.71
Past year's range: 164.09386.33

Yesterday's close: $346.21
Swings vs the market: 2.8×bigger